Investors are also suing Merck, saying it played down the risks of Vioxx and cost them billions of dollars in stock value after the drug was removed from the market.

投资者表示，他们也正在起诉默克制药公司。由于默克制药公司有意淡化了万络的风险，在万络退出市场之后，投资者在股市中损失了数十亿美元。